The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
iwCLL 2017 | Issues in patient-physician communication in CLL patients
Paolo Ghia, MD, PhD from the San Raffaele Hospital, Milan, Italy, talks to us about his collaboration with Kostas Stamatopoulos, MD, PhD, in improving communication between physicians and patients. He notes the difficulty faced by doctors in providing information to patients with chronic lymphocytic leukemia (CLL) due to the fact that the disease mainly involves a ‘wait and watch’ approach, which may cause patients to be concerned. This video was recorded at the International Workshop on Chronic Lymphocytic Leukemia (iwCLL) 2017 in New York, NY.
